SCHEMBL3165486

SCHEMBL3165486

C#Cc1c(Oc2cc(F)c(OC(F)(F)F)cc2F)ncnc1OC1CCN(OC(=O)OC(C)C)CC1

nearest known ligand 0.42

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 20/20 0.42
CYP2C9 P11712 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL391228 0.88 GPR119 (0.54) GPR119CYP2C9
SCHEMBL3164847 0.85 GPR119 (0.46) GPR119CYP2C9
SCHEMBL3161258 0.84 GPR119 (0.51) GPR119CYP2C9
SCHEMBL27734823 0.84 GPR119 (0.41) GPR119CYP2C9
SCHEMBL3155204 0.83 GPR119 (0.63) GPR119CYP2C9
SCHEMBL3174870 0.83 GPR119 (0.45) GPR119CYP2C9
SCHEMBL3155015 0.82 GPR119 (0.45) GPR119CYP2C9
SCHEMBL3164031 0.80 GPR119 (0.43) GPR119CYP2C9
SCHEMBL388385 0.79 GPR119 (0.53) GPR119CYP2C9
SCHEMBL3170581 0.79 GPR119 (0.42) GPR119CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1644357-B9 TRISUBSTITUTED ARYL AND HETEROARYL DERIVATIVES AS MODULATORS OF METABOLISM AND THE PROPHYLAXIS AND TREATMENT OF DISORDERS RELATED THERETO ARENA PHARM INC (US) 2010-03-24 EP claimed
EP-1644357-B1 TRISUBSTITUTED ARYL AND HETEROARYL DERIVATIVES AS MODULATORS OF METABOLISM AND THE PROPHYLAXIS AND TREATMENT OF DISORDERS RELATED THERETO ARENA PHARM INC (US) 2007-12-12 EP claimed